BRADLEY FOSTER & SARGENT INC/CT - RXSIGHT INC ownership

Quarter-by-quarter ownership
BRADLEY FOSTER & SARGENT INC/CT ownership history of RXSIGHT INC
ValueSharesWeighting
Q3 2023$1,651,2190.0%57,3340.0%0.04%0.0%
Q2 2023$1,651,219
+72.7%
57,3340.0%0.04%
+52.2%
Q1 2023$956,331
+31.2%
57,334
-0.3%
0.02%
+27.8%
Q4 2022$728,639
+5.9%
57,509
+0.3%
0.02%
-5.3%
Q3 2022$688,000
-12.8%
57,334
+2.3%
0.02%
-5.0%
Q2 2022$789,000
+133.4%
56,069
+105.4%
0.02%
+185.7%
Q1 2022$338,000
-4.0%
27,292
-12.7%
0.01%0.0%
Q4 2021$352,000
-9.5%
31,273
+1.9%
0.01%
-22.2%
Q3 2021$389,00030,6780.01%
Other shareholders
RXSIGHT INC shareholders Q4 2023
NameSharesValueWeighting ↓
Divisadero Street Capital Management, LP 680,000$18,965,2005.98%
NEXT CENTURY GROWTH INVESTORS LLC 747,827$20,856,8952.27%
Parkman Healthcare Partners LLC 381,331$10,635,3221.95%
Atika Capital Management LLC 509,352$14,205,8281.86%
RA Capital Management 3,052,796$85,142,4801.68%
EAM Investors, LLC 163,168$4,550,7560.88%
No Street GP LP 250,000$6,972,5000.83%
ADVISORY RESEARCH INC 156,189$4,356,1120.60%
Lisanti Capital Growth, LLC 123,205$3,436,1870.54%
Alpha DNA Investment Management LLC 20,879$582,3150.24%
View complete list of RXSIGHT INC shareholders